Literature DB >> 31813342

Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis.

Assad Hayat1, Brian J Piper1,2,3.   

Abstract

Many patients have reported that they decrease their use of opioids after starting medical cannabis (MC) but less is known for alcohol. The objective of this exploratory study was to identify any factors which differentiate alcohol abaters from those that do not modify their alcohol use after starting MC (non-abaters). Comparisons were made to identify any demographic, dosing, or health history characteristics which differentiated alcohol abaters (N = 47) from non-abaters (N = 65). Respondents selected from among a list of 37 diseases/health conditions (e.g. diabetes, sleep disorders). Abaters and non-abaters were indistinguishable in terms of sex, age, or prior drug history. A greater percentage of abaters (59.6%) than non-abaters (40.6%, p < .05) reported using MC two or more times per day. Abaters were more likely to be employed (68.1%) than non-abaters (51.1%, p < .05). Abaters also reported having significantly more health conditions and diseases (3.3 ± 2.0) than non-abaters (2.4 ± 1.4, p < .05). This small study offers some insights into the profile of patients whose self-reported alcohol intake decreased following initiation of MC. Additional prospective or controlled research into the alcohol abatement phenomenon following MC may be warranted.

Entities:  

Keywords:  Alcohol misuse; cannabidiol; marijuana; tetrahydrocannabinol

Mesh:

Substances:

Year:  2019        PMID: 31813342      PMCID: PMC7275884          DOI: 10.1080/02791072.2019.1694199

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  50 in total

1.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.

Authors:  Marcus A Bachhuber; Brendan Saloner; Chinazo O Cunningham; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

2.  Marijuana use and tobacco smoking cessation among heavy alcohol drinkers.

Authors:  Jane Metrik; Nichea S Spillane; Adam M Leventhal; Christopher W Kahler
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

3.  Self-administered web-based timeline followback procedure for drinking and smoking behaviors in young adults.

Authors:  Sandra Yu Rueger; Constantine J Trela; Michael Palmeri; Andrea C King
Journal:  J Stud Alcohol Drugs       Date:  2012-09       Impact factor: 2.582

4.  Chronic pain patients' perspectives of medical cannabis.

Authors:  Brian J Piper; Monica L Beals; Alexander T Abess; Stephanie D Nichols; Maurice W Martin; Catherine M Cobb; Rebecca M DeKeuster
Journal:  Pain       Date:  2017-07       Impact factor: 6.961

5.  Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.

Authors:  Brian J Piper; Rebecca M DeKeuster; Monica L Beals; Catherine M Cobb; Corey A Burchman; Leah Perkinson; Shayne T Lynn; Stephanie D Nichols; Alexander T Abess
Journal:  J Psychopharmacol       Date:  2017-04-04       Impact factor: 4.153

6.  Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.

Authors:  Meenakshi Sabina Subbaraman; Jane Metrik; Deidre Patterson; Robert Swift
Journal:  Addiction       Date:  2017-01-10       Impact factor: 6.526

7.  Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers.

Authors:  David Ted George; David W Herion; Cheryl L Jones; Monte J Phillips; Jacqueline Hersh; Debra Hill; Markus Heilig; Vijay A Ramchandani; Christopher Geyer; David E Spero; Erick D Singley; Stephanie S O'Malley; Raafat Bishai; Robert R Rawlings; George Kunos
Journal:  Psychopharmacology (Berl)       Date:  2009-11-10       Impact factor: 4.530

8.  Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial.

Authors:  Michael Soyka; Gabriele Koller; Peggy Schmidt; Otto-Michael Lesch; Markus Leweke; Christoph Fehr; Horst Gann; Karl F Mann
Journal:  J Clin Psychopharmacol       Date:  2008-06       Impact factor: 3.153

9.  Brief report: the association between recreational versus therapeutic marijuana use on hazardous alcohol consumption and alcohol-associated behavioral consequences among adults living with HIV in Florida.

Authors:  Zachary L Mannes; Erin G Ferguson; Larry E Burrell; Robert L Cook; Nicole Ennis
Journal:  Harm Reduct J       Date:  2018-12-07

10.  Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.

Authors:  Kevin J Simpson; Matthew T Moran; Michelle L Foster; Dipam T Shah; Daniel Y Chung; Stephanie D Nichols; Kenneth L McCall; Brian J Piper
Journal:  BMJ Open       Date:  2019-04-29       Impact factor: 2.692

View more
  1 in total

1.  Dual trajectories of cannabis and alcohol use among young adults in a state with legal nonmedical cannabis.

Authors:  Katarina Guttmannova; Charles B Fleming; Isaac C Rhew; Devon Alisa Abdallah; Megan E Patrick; Jennifer C Duckworth; Christine M Lee
Journal:  Alcohol Clin Exp Res       Date:  2021-06-05       Impact factor: 3.928

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.